Jansen E Duco, Pickett Patrick M, Mackanos Mark A, Virostko John
Vanderbilt University, Department of Biomedical Engineering, VU Station B #351631, Nashville, Tennessee 37235, USA.
J Biomed Opt. 2006 Jul-Aug;11(4):041119. doi: 10.1117/1.2337651.
In vivo bioluminescence imaging (BLI) is a powerful method of in vivo molecular imaging based on the use of optically active luciferase reporter genes. Although this method provides superior sensitivity relative to other in vivo imaging methods, spatial resolution is poor due to light scattering. The objective of this study was to use hyperosmotic agents to reduce the scattering coefficient and hence improve spatial resolution of the BLI method. A diffusing fiber tip was used to simulate an isotropic point source of bioluminescence emission (550 to 650 nm). Mouse skin was treated in vitro and in vivo with glycerol (50%, 30 min) and measurements of optical properties, and imaging photon counts were made before, during, and after application of glycerol to the skin sample. Glycerol application to mouse skin had little effect on the absorption coefficient but reduced the reduced scattering coefficient by more than one order of magnitude. This effect was reversible. Consequently, the spot size (i.e., spatial resolution) of the bioluminescence point source imaged through the skin decreased by a factor of 2 (550-nm light) to 3 (650-nm light) after 30 min. Simultaneously, an almost twofold decrease in the amount of light detected by the BLI system was observed, despite the fact that total transmission increased 1.7 times. We have shown here that multiply scattered light is responsible for both observations. We have shown that applying a hyperosmotic clearing agent to the skin of small rodents has the potential to improve spatial resolution of BLI owing to a reduction in the reduced scattering coefficient in the skin by one order of magnitude. However, reducing the scattering coefficient reduces the amount of light reaching the camera due to a reduction in the amount of multiply scattered light that reaches the camera aperture and thus reducing the sensitivity of the method.
体内生物发光成像(BLI)是一种基于使用光学活性荧光素酶报告基因的强大的体内分子成像方法。尽管该方法相对于其他体内成像方法具有更高的灵敏度,但由于光散射,其空间分辨率较差。本研究的目的是使用高渗剂降低散射系数,从而提高BLI方法的空间分辨率。使用漫射光纤尖端模拟生物发光发射(550至650nm)的各向同性点源。在体外和体内用甘油(50%,30分钟)处理小鼠皮肤,并在将甘油应用于皮肤样品之前、期间和之后测量光学性质并进行成像光子计数。将甘油应用于小鼠皮肤对吸收系数影响不大,但使约化散射系数降低了一个多数量级。这种效果是可逆的。因此,30分钟后,通过皮肤成像的生物发光点源的光斑尺寸(即空间分辨率)减小了2倍(550nm光)至3倍(650nm光)。同时,尽管总透射率增加了1.7倍,但BLI系统检测到的光量几乎减少了一半。我们在此表明,多次散射光导致了这两种现象。我们已经表明向小型啮齿动物的皮肤应用高渗清除剂有可能提高BLI的空间分辨率,这是由于皮肤中的约化散射系数降低了一个数量级。然而,降低散射系数会减少到达相机的光量,这是因为到达相机光圈的多次散射光量减少从而降低了该方法的灵敏度。